Cel-Sci Corp.

NYSE American: CVM    
Share price (4/15/24): $1.59    
Market cap (4/15/24): $85.8 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.10
from 8-K 1 page Extension of Employment Agreement
12/34/56
EX-10.11
from 8-K 1 page Extension of Employment Agreement
12/34/56
EX-10.10
from 8-K 1 page Extension of Employment Agreement
12/34/56
EX-10.11
from S-1 18 pages Securities Purchase Agreement Between Cel-Sci Corporation and Ergomed PLC Dated as of June 29, 2020 1
12/34/56
EX-10.10
from S-1 15 pages May 27, 2020 Confidential Mr. Geert R. Kersten Director and Chief Executive Officer Cel-Sci Corporation 8229 Boone Boulevard, Suite 802 Vienna, Virginia 22182 Re: Warrant Solicitation Engagement
12/34/56
EX-10.9
from S-1 22 pages Securities Purchase Agreement With Ergomed
12/34/56
EX-10.8
from 8-K 2 pages Cel-Sci Corporation 2019 Stock Compensation Plan
12/34/56
EX-10.7
from 8-K 3 pages Cel-Sci Corporation 2019 Non-Qualified Stock Option Plan
12/34/56
EX-10.9
from 8-K 5 pages Employment Agreement
12/34/56
EX-10.8
from 8-K 5 pages Employment Agreement
12/34/56
EX-10.7
from 8-K 5 pages Employment Agreement
12/34/56
EX-10.6
from 8-K 14 pages Securities Purchase Agreement Between Cel-Sci Corporation and Ergomed PLC Dated as of August 15, 2019
12/34/56
EX-10.5
from 8-K 16 pages Securities Purchase Agreement Between Cel-Sci Corporation and Ergomed PLC Dated as of August 30, 2018 1
12/34/56
EX-10.4
from 8-K 31 pages Securities Purchase Agreement
12/34/56
EX-10.3
from 8-K 19 pages Securities Purchase Agreement Between Cel-Sci Corporation and Ergomed PLC Dated as of May 16, 2018
12/34/56
EX-10.1
from S-1 28 pages Securities Purchase Agreement
12/34/56
EX-10.XXX
from S-1 2 pages Amendment to Convertible Notes
12/34/56
EX-10.ZZZ
from 8-K 19 pages Securities Purchase Agreement Between Cel-Sci Corporation and Ergomed PLC Dated as of January 1, 2018
12/34/56
EX-10
from 8-K ~5 pages Exhibit 10 (Www)
12/34/56
EX-10.(VVV)
from 8-K 35 pages Securities Purchase Agreement
12/34/56